CD4 and hepatitis B virus infection: Users of 3TC+TDF have a favorable profile regarding virological suppression and CD4+ T lymphocyte response (60); it is an interchangeable regimen with low rates of relative risk and few resistant strains (61) that can also be administered in cases of hepatitis B coinfection (62).